论文部分内容阅读
目的：探究血清肿瘤标志物联合检测在常见恶性肿瘤筛查中的应用价值。方法选取2010年1月~2016年1月在我社区进行体检的124例恶性肿瘤患者临床资料为研究对象，并选取同期体检健康者124例为健康组，所有患者均进行AFP、CEA、CA125、CA19-9、CA153、铁蛋白(FER)检测，对比检测结果。结果恶性肿瘤组患者AFP、CEA、CA125、CA19-9、CA153、FER肿瘤标志物水平明显高于对照组，差异有统计学意义（<0.05）；恶性肿瘤AFP、CEA、CA125、CA19-9、CA153、FER指标单项检测率均明显低于联合检测率，差异有统计学意义（<0.05）。结论血清肿瘤标志物联合检测在常见恶性肿瘤筛查中具有重要的价值。“,”Objective To explore the serum tumor markers combined detection in common malignant tumor screening the application value. Methods between January 2014 and January 2016 in my community medical examination during the period of 124 malignant tumor patients clinical data as the research object, and USES the same medical group, 124 cases of healthy subjects for health, all patients with AFP, CEA, CA125, CA19-9, CA153, ferritin (FER), contrast test results. Results The patients with malignant tumor group of AFP, CEA, CA125, CA19-9, CA153, FER tumor markers level obviously higher than that of control group, the difference was statistically significant ( <0.05);AFP, CEA, CA125, malignant tumors CA19-9, CA153, FER index single detection rate is significantly lower than the joint detection rate, the difference was statistically significant ( < 0.05). Conclusion The serum tumor markers combined detection has important value in common malignant tumor screening.